We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$317M
AUM Growth
+$38.8M
Cap. Flow
-$1.56B
Cap. Flow %
-492.71%
Top 10 Hldgs %
57.22%
Holding
73
New
24
Increased
15
Reduced
14
Closed
19

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$15.5M
2
EHC icon
Encompass Health
EHC
+$10.3M
3
COR icon
Cencora
COR
+$9.71M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.22M
5
BDX icon
Becton Dickinson
BDX
+$8.96M

Top Sells

Rank Stock Value
1
RCM
R1 RCM Inc. Common Stock
RCM
+$24.4M
2
HCA icon
HCA Healthcare
HCA
+$18M
3
JNJ icon
Johnson & Johnson
JNJ
+$13.9M
4
CRL icon
Charles River Laboratories
CRL
+$9.93M
5
WMGI
Wright Medical Group Inc
WMGI
+$7.59M

Sector Composition

Rank Sector Weight
1 Healthcare 89.13%
2 Industrials 1.01%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMY icon
1
Bristol-Myers Squibb
BMY
$133B
$25.8M 8.12%
401,434
+109,509
+38% +$6.27M
ELV icon
2
Elevance Health
ELV
$81.5B
$24.8M 7.81%
82,043
+56,386
+220% +$15.5M
ZBH icon
3
Zimmer Biomet
ZBH
$18.2B
$20.4M 6.42%
140,249
-16,822
-11% -$2.32M
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$20.2M 6.37%
1,218,029
+228,593
+23% +$3.71M
COR icon
5
Cencora
COR
$60.6B
$18.6M 5.86%
218,820
+113,319
+107% +$9.71M
LH icon
6
Labcorp
LH
$25B
$18.3M 5.76%
125,762
+22,186
+21% +$3.2M
CI icon
7
Cigna
CI
$73.7B
$16.5M 5.2%
80,739
+8,630
+12% +$1.58M
BDX icon
8
Becton Dickinson
BDX
$45.6B
$15.5M 4.89%
58,559
+35,946
+159% +$8.96M
EHC icon
9
Encompass Health
EHC
$11B
$11.3M 3.56%
205,007
+190,059
+1,271% +$10.3M
REGN icon
10
Regeneron Pharmaceuticals
REGN
$78.5B
$10.3M 3.24%
+27,390
New +$9.22M
SIBN icon
11
SI-BONE Inc
SIBN
$788M
$10.1M 3.19%
+470,429
New +$8.44M
ABBV icon
12
AbbVie
ABBV
$443B
$8.73M 2.75%
98,596
-63,411
-39% -$5.26M
IQV icon
13
IQVIA
IQV
$38.7B
$7.69M 2.42%
+49,781
New +$7.27M
HRC
14
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$7.47M 2.35%
+65,843
New +$6.94M
PRAH
15
DELISTED
PRA Health Sciences, Inc.
PRAH
$6.56M 2.07%
58,983
-67,826
-53% -$6.98M
IRTC icon
16
iRhythm Holdings
IRTC
$3.85B
$6.1M 1.92%
+89,614
New +$6.08M
EVH icon
17
Evolent Health
EVH
$348M
$5.41M 1.7%
+597,303
New +$4.85M
SPY icon
18
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$5.34M 1.68%
16,600
-49,600
-75% -$15.3M
ZTS icon
19
Zoetis
ZTS
$32.4B
$5.32M 1.68%
40,197
-20,802
-34% -$2.58M
SRPT icon
20
Sarepta Therapeutics
SRPT
$1.57B
$5.14M 1.62%
+39,822
New +$4.02M
IOVA icon
21
Iovance Biotherapeutics
IOVA
$1.82B
$4.67M 1.47%
168,546
+82,477
+96% +$1.88M
MDRX
22
DELISTED
Veradigm Inc. Common Stock
MDRX
$4.4M 1.39%
+447,986
New +$4.72M
ACRS icon
23
Aclaris Therapeutics
ACRS
$726M
$3.88M 1.22%
2,055,069
+285,284
+16% +$473K
PRNB
24
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$3.62M 1.14%
+66,157
New +$2.47M
LAB icon
25
Standard BioTools
LAB
$340M
$3.6M 1.13%
1,034,633
+638,932
+161% +$2.25M
1
2 3

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Endurant Capital Management held 73 positions worth $317M, up 14% from $279M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Endurant Capital Management withdrew a net $1.56B in Q4 2019, closing 19 positions and reducing 14 holdings. Its most notable exit was HCA Healthcare, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 77% a quarter earlier, followed by Industrials and Technology.

Against the trend, Endurant Capital Management opened a new position in Regeneron Pharmaceuticals worth $10.3M.

  • Endurant Capital Management's largest Q4 2019 buy was Regeneron Pharmaceuticals: 27,390 shares worth $10.3M.
  • Endurant Capital Management added most to Elevance Health in Q4 2019, an estimated $15.5M increase.
  • Endurant Capital Management's biggest Q4 2019 reduction was R1 RCM Inc. Common Stock, cutting an estimated $24.4M.
  • Endurant Capital Management fully exited HCA Healthcare in Q4 2019, selling an estimated $18M.
  • Endurant Capital Management's ten largest holdings make up 57% of its $317M portfolio in Q4 2019.
  • Endurant Capital Management opened 24 new positions and closed 19 in Q4 2019.
  • Endurant Capital Management's portfolio value rose 14% quarter-over-quarter to $317M.

Based on Endurant Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.